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Abstract
Introduction:  Spontaneous retroperitoneal hemorrhage is a distinct clinical entity that can
present as a rare life-threatening event characterized by sudden onset of bleeding into the
retroperitoneal space, occurring in association with bleeding disorders, intratumoral bleeding, or
ruptures of any retroperitoneal organ or aneurysm. The spontaneous form is the most infrequent
retroperitoneal hemorrhage, causing significant morbidity and representing a diagnostic challenge.
Case presentation: We report the case of a patient with coronary artery disease who presented
with transient ischemic attack, in whom anticoagulant therapy with heparin precipitated a massive
spontaneous atraumatic retroperitoneal hemorrhage (with international normalized ratio 2.4),
which was treated conservatively.
Conclusion: Delay in diagnosis is potentially fatal and high clinical suspicion remains crucial. Finally,
it is a matter of controversy whether retroperitoneal hematomas should be surgically evacuated
or conservatively treated and the final decision should be made after taking into consideration
patient's general condition and the possibility of permanent femoral or sciatic neuropathy due to
compression syndrome.
Introduction
Hemorrhage is the most important complication of
unfractionated heparin in patients with atrial fibrillation
(AF) treated with oral vitamin K antagonist (VKA) during
hospitalization or among those receiving anticoagulants
in terms of emergency or elective cardiac surgery [1,2] or
in the initial treatment of deep venous thrombosis [3,4].
Analysis of the data presented by the European AF Trial
Study Group [5] shows that as the international normal-
ized ratio (INR) increased, there was an increase in the risk
of major bleeding, such that at INR ≥ 5.0, the risk of bleed-
ing increased 3.6-fold relative to INR ≤ 2. The optimal
intensity of anticoagulation that achieved maximum ther-
apeutic effect with minimum risk was determined to be at
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INR = 3.0. These data, along with recommendations from
the recent American College of Chest Physicians (ACCP)
guidelines, indicate that the optimal intensity of anticoag-
ulation for balancing efficacy in presenting stoke, while
minimizing the risk of bleeding, is within the range INR =
2.0–3.0 (see [6]). Among outpatients receiving oral anti-
coagulants those with INR ≥ 6.0 face a significant risk of
major hemorrhage [7].
Retroperitoneal hemorrhage is most frequently seen after
femoral artery catheterization or pelvic and lumbar
trauma [8-10]. In the absence of trauma, retroperitoneal
hemorrhage most frequently results from a ruptured
abdominal aortic aneurysm or bleeding from an underly-
ing condition in the kidneys or adrenal glands. Spontane-
ous retroperitoneal hemorrhage (SRH) denotes bleeding
without any known inciting trauma or underlying retro-
peritoneal pathology. SRH is uncommon and is almost
exclusively seen in association with anticoagulation states,
coagulopathies and hemodialysis [11,12].
A plethora of conditions have been used as a possible
hypothesis of the pathophysiology of SRH. Unrecognized
minor trauma in the microcirculation in the presence of
coagulopathy has been suggested [13,14].
The surgeons' quiver contains various types of approach
to the treatment of this relatively uncommon complica-
tion such as conservative management, angiographic eval-
uation, percutaneous embolization or surgical
intervention.
Case presentation
A 57-year-old Caucasian male was admitted to our hospi-
tal presenting with focal ischemic cerebral neurological
deficit of acute onset. The patient had had an acute non-
Q-wave myocardial infarction episode 11 years ago and
post-infarct had undergone percutaneous transluminal
coronary angioplasty: ramus circumflexus in 1995 and
ramus diagonalis I in 1997. Eleven months before admis-
sion, an evaluation elsewhere had revealed persistent
atrial fibrillation and since this evaluation the patient had
been receiving Warfarin and had maintained INR = 2.0–
2.5.
On the day of admission, examination of the patient
revealed intense dizziness with diplopia, instability and
complete left-sided homonymous hemianopsia. The find-
ings suggested a transient ischemic attack involving the
anterior circulation: carotid artery territory.
There was no personal or family history of coagulopathy
or stroke, valvular heart disease trauma, chest pain or
illicit intravenous drug usage. He smoked 20 cigarettes
daily and consumed alcohol in moderation in the past.
The prothrombin was normal, INR = 2.4, the partial
thromboplastin time was 45 seconds, the values for urea,
nitrogen, creatinine, glucose, uric acid, bilirubin, phos-
phorus, electrolytes, creatinine kinase, lactate dehydroge-
nase, amylase and alkaline phosphatase were normal. An
electrocardiogram (ECG) revealed atrial fibrillation at a
rate of 110, with nonspecific ST-segment and T-wave
abnormalities. A radiograph of the chest showed clear
lungs and slight cardiac enlargement. A cardiac ultrasono-
graphic examination showed no vegetations, intracardiac
MRI – axial plan showing a large, mixed density mass in the  right side of the abdomen suggestive of a large retroperito- neal hematoma, with areas of hyperdensity (arrows) indicat- ing ongoing hemorrhage Figure 2
MRI – axial plan showing a large, mixed density mass 
in the right side of the abdomen suggestive of a large 
retroperitoneal hematoma, with areas of hyperden-
sity (arrows) indicating ongoing hemorrhage.
MRI – transverse plan (L4) with IV contrast gadolinium- BOPTA, revealing a well-defined mass, a huge retroperito- neal hematoma Figure 1
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thrombus, segmental wall-motion abnormalities or int-
racardiac shunts. A test for the erythrocyte sedimentation
rate was normal, as were tests for antinuclear antibodies,
lupus anticoagulant and antiphospholipid antibody.
Computed tomography (CT) brain imaging was per-
formed without the use of contrast material, but failed to
indicate hemorrhage, infarct, abscess, tumor or cerebral
metastasis. Heparin 20,000IE/24 hours intravenously and
Metoprolol 100 mg by mouth were administered.
Repeated physical examinations and ECGs showed no
changes.
On the second hospital day the patient awoke with a
slight neurologic deficit that gradually progressed in a
stepwise fashion. Hemiplegia (upper left extremity and
face were involved), hemianesthesia and Babinski sign
contralateral to the hemiparesis were established. He had
mild dysarthria, but his speech was fluent and his compre-
hension, repetition and naming abilities were intact. CT
brain imaging was performed and no hemorrhagic trans-
formation was found. Dipyridamole 200 mg/day, Aspirin
25 mg/day, Heparin 20,000IE/24 hours and Mannitol
20% solution (1 g/kg) were administered. Daily monitor-
ing of ECG, vital signs, electrolytes, blood urea nitrogen,
creatinine, urine output showed no changes.
On the fifth hospital day the patient noted the acute onset
of pain in the lower right abdominal quadrant and lum-
bar region accompanied by mild nausea. The patient held
the right hip in flexion and external rotation. Any attempt
to straighten the leg aggravated the pain with radiation to
the medial and anterior portions of the lower extremity
Weakness of the right quadriceps femoris muscle, par-
esthesia over the anterior thigh and right flank were evi-
dent. The partial thromboplastin time was 43 seconds and
INR = 2.4.
Hematocrit level fell as did hemoglobin (Table 1). CT and
magnetic resonance imaging (MRI) scan of the abdomen
and the pelvis was obtained (Figures 1 and 2) and
revealed extensive enlargement and heterogeneity of the
right iliopsoas muscle as well as displacement of the right
kidney. The high-attenuation component in the absence
of intravenous contrast enhancement (Figure 3) is a find-
ing that is usually consistent with the presence of a large
retroperitoneal hematoma.
Transfusion of six units of packed red cells and the admin-
istration of two units of fresh frozen plasma was followed
by fluid overload. The patient was treated conservatively
and his condition promptly stabilized after the restoration
of normal blood coagulation; however, he remained in
the hospital for 38 days. Three months later he had signs
of partial lateral paresis of the right quadriceps muscle and
thigh adductors and, at 1-year follow-up, the only find-
ings were suggestive of the previous transient ischemic
Table 1: Hematologic laboratory values
On admission On fifth hospital day
Variable Value Variable Value
Hematocrit (%) 43 Hematocrit (%) 24.3
Hemoglobin (g/dl) 13.7 Hemoglobin (g/dl) 8.7
Mean corpuscular volume (μm3) 92 Platelet count (per mm3)8 5 , 0 0 0
Erythrocyte sedimentation rate (mm/hour) 130 White-cell amount (per mm3)1 4 , 9 0 0
White-cell amount (per mm3) 10,200 Prothrombin time (s) 16.1
Differential count (%) Partial thromboplastin time (s) 63
Neutrophilis 64 D-dimer test (μg/l) Negativea
Lymphocytes 27 Fibrinogen (mg/dl) 446b
Monocytes 7 Antithrombin III (mg/dl) 28c
Eosinophilis 1 Factor II (mg/dl) 14d
Basophilis 1 Factor V (mg/dl) 0.8e
Platelet count (per mm3) 265,000 Factor VII (mg/dl) 0.3f
Factor X (mg/dl) 0.8g
Prekallikrein (mg/dl) 5h
aNormal values less than 250 μg/l.
bNormal values in the range 200–400 mg/dl.
cNormal immunologic assay range 17–30 mg/dl.
dNormal values in the range 10–15 mg/dl.
eNormal values in the range 0.5–1 mg/dl.
fNormal value 0.2 mg/dl.
gNormal values in the range 0.6–0.8 mg/dl.
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attack involving the carotid artery territory; he had recov-
ered completely from the femoral neuropathy.
Discussion
The large study of Sasson et al. [15] showed that patients
who are receiving Heparin anticoagulation therapy, even
in therapeutic doses, should be carefully monitored for
the development of groin pain or leg weakness.
The most common symptoms are the acute onset, the
severity and the persistence of the patient's pain in the
lower abdominal quadrant, inguinal or lumbar region,
and its radiation to the scrotum. Pain and paresthesia
extend over the anterior, medial or lateral aspects of the
lower extremities depending on the branches of the lum-
bar plexus that are involved. The most frequently involved
nerve is the femoral nerve, the largest branch of the lum-
bar plexus which arises from the dorsal branches of L2, L3
and L4 ventral rami. It descends through the psoas major,
emerging low on its lateral border and then passes
between the psoas and iliacus, which makes the nerve vul-
nerable to traction injury from an underlying iliacus mus-
cle hematoma [16,17], deep to the iliac fascia, passing
behind the inguinal ligament into the thigh.
The diagnosis of atraumatic retroperitoneal hemorrhage
remains challenging even when high-resolution MRI and
CT imaging are used, because a large number of benign or
malignant lesions can mimic this condition [18,19].
However, despite these limitations, MRI and CT imaging
are superior to ultrasound and should be the preferred pri-
mary investigation [20-22].
The mainstay management currently consists of modifica-
tion or cessation of anticoagulation therapy according to
its clinical requirement, correction of the anticoagulation
state, volume resuscitation and hemodynamic stabiliza-
tion with adequate hematology and transfusion therapy
and supportive measures [23]. Small hematomas with
mild symptoms of neuropathy, without resultant obscura-
tion, displacement or compression of normal retroperito-
neal structures, without the need for multiple transfusions
and without signs of infection may be treated conserva-
tively.
On the other hand the effectiveness and safety of surgical
intervention and evacuation of the hematoma should be
considered as a potential strategy in uncontrollable hemo-
dynamic collapse or when the nerve involved in the
decompression might be effective in that the direct pres-
sure and pressure-induced ischemic effects are reversible
[24,25]. The latter is limited by the inability to localize or
control the bleeding vessel and the risk of worsening the
bleeding by releasing the tamponade [26].
Conclusion
The rarity of this possible complication of the intravenous
use of Heparin in patients with INR < 4.5 means that it
remains a challenge for surgeons. We strongly suggest
that, according to our experience, daily measurement of
INR and activated partial thromboplastin time (aPTT) in
patient's receiving Heparin intravenously as an anticoagu-
lation agent is of great importance. In deep vein thrombo-
sis or acute myocardial infarction, the usual protocol
requires injection of Heparin monitored by the pro-
thrombin time, aPTT or both followed by long-term ther-
apy with oral anticoagulants. As the half-life of Heparin is
3 hours, we suggest that aPTT to be measured 3 hours after
Heparin administration or 1 hour before the next dose.
Some of the most important factors for the diagnosis are
acute onset of pain, a dramatic change in the patient's
clinical status and high clinical suspicion. CT and MRI
remain the most powerful diagnostic tools. The complex
challenge for the surgeon is the choice of clinical pathway
in the management of this rare entity and this choices
should only be made after taking two key points into con-
sideration: (i) the patient's general condition; (ii) in the
presence of permanent femoral or sciatic neuropathy due
to a compression syndrome, hemodynamically unstable
patients should be managed with an emergency laparot-
omy.
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